Mechanisms in the development of analgesic nephropathy.
D000082:Acetaminophen / Q000009:adverse effects; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology; D001241:Aspirin / Q000009:adverse effects; D004357:Drug Synergism; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000139:chemically induced*; D007681:Kidney Papillary Necrosis / Q000139:chemically induced; D010615:Phenacetin / Q000009:adverse effects; D012459:Salicylates / Q000009:adverse effects; D014018:Tissue Distribution
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012459:Salicylates; D000082:Acetaminophen; D010615:Phenacetin; D001241:Aspirin